It measures 9 French (3 millimetres) in diameter upon insertion and removal from the body. While in the heart, it expands to support the heart’s pumping function, providing flow greater than 3.5 L/min
The project is a collaboration between IIT Delhi and AIIMS
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Q1 FY22 consolidated revenue grew 6% to Rs. 1,808 crore from Rs. 1,712 crore in Q1 FY21. Q1 FY22 Net Profit was Rs. 84 crore (vs. Rs. 149 crore in Q1 FY21).
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
Subscribe To Our Newsletter & Stay Updated
